Sales Training Manager, Oncology
BillionToOneFull Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
Key technologies and capabilities for this role
Common questions about this position
This is a field-based position with candidates based in Milan or Rome, or another location allowing efficient coverage of Italy. Travel is mostly within Italy, with occasional visits to Slovenia, Croatia, and Greece, totaling about 60% overall.
Key responsibilities include driving market growth by achieving sales objectives, developing strategic business plans, building customer relationships with oncologists and KOLs, collaborating on sales, providing technical expertise on oncology workflows, and training account managers.
The role requires an experienced oncology commercial professional with expertise in oncology workflows like NGS, liquid biopsy, companion diagnostics, and biomarkers, plus skills in sales, customer engagement, and technical presentations.
Illumina fosters a collaborative environment where every person has the opportunity to make a difference, surrounded by extraordinary people, inspiring leaders, and world-changing projects in genomic technology for health equity.
A strong candidate is a highly motivated oncology commercial professional who can drive sales growth, build relationships with KOLs and stakeholders, provide technical expertise in oncology solutions, and collaborate effectively with teams.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.